{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"a23204d1ea13","filters":{"venue":"AME Clinical Trials Review"}},"results":[{"id":"W4403847447","doi":"10.21037/actr-24-101","title":"A new ALK inhibitor is not a game changer, but an older one is!","year":2024,"lang":"en","type":"article","venue":"AME Clinical Trials Review","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Computer science","authors":[{"name":"Beatriz Jimenez Munarriz","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Sam Khan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.405074715952138,"gpt":0.5887407088941433,"spread":0.1836659929420054,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008264787,0.000838477,0.003000829,0.001160589,0.0005192638,0.003305063,0.001618379,0.003573199,0.01416599],"category_scores_gemma":[0.01408795,0.0004087685,0.003276699,0.001013172,0.0011599,0.006352123,0.0009476534,0.008057806,0.005092519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001164305,"about_ca_system_score_gemma":0.002411287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001723326,"about_ca_topic_score_gemma":0.005794783,"domain_scores_codex":[0.9976949,0.0009158702,0.0003608429,0.0002490599,0.0006161094,0.0001632184],"domain_scores_gemma":[0.9895167,0.006176071,0.001097994,0.0002803447,0.002229154,0.0006997654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001387236,0.0001696739,0.0002226052,0.01682211,0.0009161243,0.0001439225,0.00008411757,0.0002301995,0.001593156,0.01266262,0.3361759,0.6295924],"study_design_scores_gemma":[0.0008432781,0.0008258607,0.0005732306,0.01299499,0.00093165,0.0002866846,0.0000899896,0.00009445789,0.0002086073,0.00635919,0.9767461,0.00004602539],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.0005938994,0.8861964,0.0009649058,0.08942714,0.01633804,0.00008519158,0.0002894988,0.00007929377,0.006025712],"genre_scores_gemma":[0.009233432,0.8272732,0.004003111,0.1300167,0.01669895,0.0001884867,0.0004676391,0.00008922011,0.01202926],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.01416599,"threshold_uncertainty_score":0.04738998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403847681","doi":"10.21037/actr-24-44","title":"Utilizing therapeutic response as a criterion for PARP inhibitor maintenance therapy in advanced triple negative breast cancer; promoting personalized medicine","year":2024,"lang":"en","type":"article","venue":"AME Clinical Trials Review","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; PARP inhibitor; Breast cancer; Oncology; Medicine; Internal medicine; Cancer; Poly ADP ribose polymerase; Biology; Genetics","authors":[{"name":"Greydon Arthur","is_ca":true},{"name":"Nathalie LeVasseur","is_ca":true},{"name":"Karen A. Gelmon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.317957896190338,"gpt":0.5660474151581424,"spread":0.2480895189678044,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01349833,0.0006760229,0.00272998,0.001301293,0.0002410971,0.001934968,0.0008012044,0.001096561,0.001993001],"category_scores_gemma":[0.01487033,0.0002499328,0.001826559,0.00134396,0.000497755,0.001086065,0.0005750239,0.002739312,0.0003985308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001319401,"about_ca_system_score_gemma":0.001647149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006053451,"about_ca_topic_score_gemma":0.002236795,"domain_scores_codex":[0.9962365,0.002261101,0.0005502907,0.0002525298,0.0005956835,0.0001039042],"domain_scores_gemma":[0.9902909,0.00643169,0.001730053,0.0002636296,0.001118787,0.0001649683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006031742,0.0005154411,0.004947245,0.02573102,0.002903968,0.00007668533,0.0001091524,0.001133626,0.005403842,0.004108198,0.009675864,0.9393633],"study_design_scores_gemma":[0.01468361,0.04968021,0.06321202,0.0563259,0.03681437,0.002812003,0.0005357871,0.008317818,0.02090471,0.01169738,0.734697,0.0003192212],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01330492,0.9692415,0.003730351,0.005153423,0.0009120801,0.0008833125,0.0004078289,0.00004101494,0.006325469],"genre_scores_gemma":[0.2386918,0.7198765,0.02162394,0.01141129,0.002443562,0.001760164,0.0009654159,0.00004356991,0.003183681],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01349833,"threshold_uncertainty_score":0.07138681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407980374","doi":"10.21037/actr-24-168","title":"Unpacking prostate-specific antigen dynamics and patient outcomes: insights from the ARASENS trial","year":2025,"lang":"en","type":"article","venue":"AME Clinical Trials Review","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Unpacking; Prostate-specific antigen; Dynamics (music); Prostate; Psychology; Medicine; Internal medicine; Pedagogy","authors":[{"name":"H. Roberts","is_ca":true},{"name":"Corinne Maurice‐Dror","is_ca":true},{"name":"Kim Nguyen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1867417329315312,"gpt":0.4727159903833336,"spread":0.2859742574518024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03499696,0.0008761579,0.004138932,0.0007671915,0.0002732904,0.002785672,0.001229526,0.001756348,0.005306212],"category_scores_gemma":[0.06805817,0.0003753075,0.004488977,0.002355566,0.0009962104,0.002154712,0.001185678,0.004617302,0.000640284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001164499,"about_ca_system_score_gemma":0.00334777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002487707,"about_ca_topic_score_gemma":0.005504701,"domain_scores_codex":[0.9823497,0.01411462,0.001135245,0.0006311117,0.001330654,0.0004386582],"domain_scores_gemma":[0.9447129,0.04624559,0.004787224,0.00187428,0.001762924,0.0006171426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06296394,0.0005857028,0.02670216,0.04420218,0.07620566,0.0002067603,0.0004639653,0.004493149,0.001003811,0.02318569,0.04914633,0.7108405],"study_design_scores_gemma":[0.07891695,0.02220462,0.1630393,0.06145635,0.1430858,0.001303134,0.001015979,0.004315392,0.001739357,0.08700957,0.4352539,0.0006596252],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.022489,0.9497923,0.001307023,0.01707993,0.001288343,0.0001775098,0.001666424,0.0000301678,0.006169315],"genre_scores_gemma":[0.3302559,0.6360025,0.003729958,0.01899677,0.005096457,0.0006138179,0.00295772,0.0001080192,0.002238894],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03499696,"threshold_uncertainty_score":0.1850838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392735304","doi":"10.21037/actr-23-42","title":"CheckMate 817: expanding the pool of patients eligible for immune checkpoint inhibitor therapy in advanced non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"AME Clinical Trials Review","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Immune checkpoint; Oncology; Immune system; Immunotherapy; Cancer research; Internal medicine; Immunology","authors":[{"name":"Ziad Baloush","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1245475041873629,"gpt":0.4786354094011026,"spread":0.3540879052137397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002113634,0.0002968535,0.001514657,0.0004762797,0.0002346847,0.001291789,0.0007537976,0.0007996469,0.008633564],"category_scores_gemma":[0.003404346,0.0001394128,0.001579107,0.0004558666,0.0002645245,0.00105321,0.0008480148,0.001872071,0.0009827628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008433251,"about_ca_system_score_gemma":0.001115175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008678143,"about_ca_topic_score_gemma":0.0044308,"domain_scores_codex":[0.9994625,0.0002602321,0.00004064268,0.00006878782,0.00008795025,0.00007988435],"domain_scores_gemma":[0.9989032,0.0005972891,0.0001530433,0.00002602104,0.0001108736,0.0002096745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03130756,0.0009861724,0.006634314,0.006818875,0.001387681,0.000096524,0.000109908,0.001659709,0.003182726,0.003233345,0.05941502,0.8851682],"study_design_scores_gemma":[0.180652,0.0601825,0.1118234,0.01439545,0.008733708,0.001273521,0.0005388646,0.00648859,0.004381841,0.01153455,0.5997939,0.0002019237],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3678059,0.5270071,0.003023949,0.04410078,0.006446497,0.002888215,0.005682973,0.0004002358,0.04264432],"genre_scores_gemma":[0.7279096,0.2077221,0.004411631,0.03687769,0.002628531,0.002279873,0.006317737,0.00009154729,0.01176129],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008633564,"threshold_uncertainty_score":0.02888209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401922562","doi":"10.21037/actr-24-34","title":"Chemo-immunotherapy on localized gastroesophageal/gastric adenocarcinoma—hope or delusion?","year":2024,"lang":"en","type":"article","venue":"AME Clinical Trials Review","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Delusion; Immunotherapy; Gastroesophageal Junction; Cancer; Medicine; Adenocarcinoma; Internal medicine; Gastroenterology; Psychiatry","authors":[{"name":"Marcelo Porfírio Sunagua Aruquipa","is_ca":false},{"name":"Renata D’Alpino Peixoto","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2471063106414863,"gpt":0.5112828568609188,"spread":0.2641765462194325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005207261,0.0005126487,0.00327941,0.0007703805,0.0002691335,0.002163121,0.0009096689,0.001809971,0.005284732],"category_scores_gemma":[0.006889367,0.0002830847,0.002290875,0.001140973,0.0006206752,0.001733338,0.0006626346,0.002905007,0.0008104974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008192366,"about_ca_system_score_gemma":0.001766176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008645806,"about_ca_topic_score_gemma":0.003810993,"domain_scores_codex":[0.9988582,0.0006029167,0.0002096916,0.00008177834,0.0001599476,0.00008745108],"domain_scores_gemma":[0.9961526,0.002410876,0.0006419017,0.00007363135,0.0005388061,0.000182238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005492407,0.0002337572,0.0009572593,0.06998882,0.00345731,0.0001223686,0.0001100638,0.0003803316,0.001527003,0.004371846,0.05593126,0.8574275],"study_design_scores_gemma":[0.01071317,0.008027366,0.006282074,0.1011847,0.01567689,0.0008930534,0.0003653482,0.0004540077,0.0009092533,0.005418591,0.8499914,0.00008404708],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.0006174112,0.9940907,0.00005781698,0.003753097,0.0006159159,0.00002535498,0.00004644267,0.000003508846,0.0007897186],"genre_scores_gemma":[0.01207766,0.9729424,0.0004391431,0.01161216,0.001740613,0.00009339773,0.0001121619,0.00000587006,0.0009766999],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.005284732,"threshold_uncertainty_score":0.02753896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}